More than 300 members, representing 42 University departments, are working together to improve the understanding of cancer and to develop new lifesaving procedures in cancer prevention, diagnosis, and treatment. UPMC Hillman Cancer Center research programs range from basic science programs that examine the molecular basis of cancer development and progression in the laboratory, to translational and clinical programs that implement novel laboratory findings into clinical trials in humans, to population-based programs that focus on cancer prevention, epidemiology, and biobehavioral factors in cancer.
Research Program Leaders
| Robert L. Ferris, MD, PhD | Director, UPMC Hillman Cancer Center |
| Catherine Bender, PhD | Co-Leader, Biobehavioral Cancer Control Program |
| Dana Bovbjerg, PhD | Co-Leader, Biobehavioral Cancer Control Program |
| Adam Brufsky, MD, PhD | Co-Leader, Cancer Therapeutics Program |
| Ronald Buckanovich, MD, PhD | Co-Leader, Cancer Biology Program |
| Shou-Jiang (SJ) Gao, PhD | Co-Leader, Cancer Virology Program |
| Haitao Guo, PhD | Co-Leader, Cancer Virology Program |
| James Herman, MD | Co-Leader, Cancer Epidemiology and Prevention Program |
| Steffi Oesterreich, PhD | Co-Leader, Cancer Biology Program |
| Patricia Opresko, PhD | Co-Leader, Genome Stability Program |
| Taofeek K. Owonikoko, MD, PhD | Associate Director, Translational Research; Co-Leader, Cancer Therapeutics Program |
| Bennett Van Houten, PhD | Co-Leader, Genome Stability Program |
| Dario Vignali, PhD | Co-Leader, Cancer Immunology and Immunotherapy Program |
| Peter Wipf, PhD | Co-Leader, Cancer Therapeutics Program |
| Jian-Min Yuan, MD, PhD | Associate Director, Cancer Control and Population Sciences; Co-Leader, Cancer Epidemiology and Prevention Program |
| Hassane Zarour, MD | Co-Leader, Cancer Immunology and Immunotherapy Program |
